DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to invest in for the next 2 years. On April 30, DexCom reported Q1 ...

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in ...

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...

They offer investors very different value propositions.

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market close. Here’s what ...

San Diego device maker Dexcom has received the first FDA clearance for a continuous glucose monitor that doesn’t require a doctor’s prescription. The U.S. Food and Drug Administration cleared Dexcom’s ...

DexCom has partnered with Google Life Sciences to develop the next generation of DexCom's CGM -- a device that is "the size of a dime", less expensive than current CGMs, and that the companies hope ...

Dexcom has opted not to raise its FY26 revenue outlook due to the current geopolitical environment.